NVCR - NovoCure Ltd (Healthcare: Medical Instruments & Supplies) Projected Earnings Date: 2025-07-24    (Delayed quote data   2025-05-09)
Last
 17.38		 Change
 ⇓ -0.06   (-0.34%)		 Volume
  1,001,086
Open
 17.52		 High
 17.69		 Low
 17.20
8EMA (Daily)
 17.48		 40EMA (Daily)
 18.15		 50EMA (Daily)
 18.55		 STO (Daily)
 54.050		 MACD Hist (Daily)
 0.122
8EMA (Weekly)
 18.079		 40EMA (Weekly)
 20.43		 50EMA (Weekly)
 21.02		 STO (Weekly)
 20.012		 MACD Hist (Weekly)
 -0.895
Company Profile
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com